Ayurcann Cannabis Co. Reports 28% YoY Net Revenue Growth In Q1 With Strong Performance In Vapes And Pre-Rolls

Zinger Key Points
  • Ayurcann's Q1 2025 revenue rose 25% YoY to CA$8.3M, driven by strong sales in vapes and pre-rolls.
  • The company's net loss widened to CA$356,711, impacted by higher expenses and operational costs.
  • Ayurcann's cash decreased to CA$891K, down from CA$1.5M in the prior year's Q1.

Ayurcann Holdings Corp. AYUR AYURF, a Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announced on Thursday its first quarter financial and operational results for the three months ended Sept. 30, 2024.

The Toronto-based company highlighted a 25% year-over-year increase in gross revenue, strong gross margin and top market presence in the vapes and pre-roll category in Ontario during the period.

Ayurcann noted that fiscal 2024 and the beginning of fiscal 2025 was a pivotal time for the company and the broader cannabis industry in Canada. CEO Igal Sudman said the company's business model and disciplined execution have allowed Ayurcann to expand across all levels.

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

"By focusing on innovation, building strong partnerships, and growing our signature brands—such as Fuego, Xplor, Xplor LevelX and Happy & Stoned—we continue to deliver consistent quarter-over-quarter growth,” Sudman said. “Our vision remains clear: to become a dominant player in the cannabis industry.”

Read Also: Marijuana Extraction Company Ayurcann Reports Record Gross Revenue For Fiscal Year 2024

Q1 2025 Financial Highlights

  • After deducting agency and service fees (CA$102,783) and excise duties (CA$6.35 million), net revenue stood at CA$8.3 million, an increase from CA$6.5 million in the prior year's period, representing a 28% increase year-over-year.
  • Expenses amounted to CA$3.3 million, up from CA$2.3 million in the same quarter of 2023.
  • Net loss and comprehensive loss was CA$356,711, compared to roughly CA$209,000.
  • Cash at the end of the period was CA$891,783, down from CA$1.5 million in the prior year's period.

Read Next:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.